SUBSCribe
logo
twitterlinkedininstagramUser Profile
search
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • Spotlight Initiatives
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
          • LEADING EDGE
          • SMART ENTERPRISE
        • At Home With Art

          Novartis India’s Ranjit Shahani’s enviable collection reflects his journey from a novice to an expert in contemporary art

          Krishna Gopalan - August 19, 2017
        • Managing Growth 2017- Part 2

          Will demonetisation hurt? Can the Budget spur a growth recovery? Here's what four CEOs predicted for the next fiscal

          March 17, 2017
        • Managing Growth 2017- Part 1

          CEOs from diverse sectors on what's in store for 2017

          March 17, 2017
        • Will Sun rise again?

          Can Sun Pharma’s Dilip Shanghvi work his merger magic on Ranbaxy?

          Kripa Mahalingam - June 15, 2015
        • Critical condition

          Drug majors are shifting clinical trials out of India as lawmakers turn on the heat

          Kripa Mahalingam - June 17, 2015

        Latest Edition

        magcover
        February 01, 2023
        magcover
        January 01, 2023
        magcover
        December 01, 2022
        magcover
        November 01, 2022
        twitterlinkedininstagramUser Profile
        • BIG STORY
        • PERSPECTIVE
        • ENTERPRISE
        • STRATEGY
        • MARKETS
        • PIXTORY
        • SPECIALS
        • VIDEOS
        • WOMEN
        • C'EST LA VIE
        • MAGAZINE
        About us Contact usPrivacy PolicyTerms and ConditionsSitemap
        Copyright © 2019 Outlook Business!. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.